RxDoctor Payments Data

Julie Schaefer, PA

Physician Assistant · Erie, PANPI 1710967195

Payments from drug & device makers

$719in general payments, 2019–2025

Across 33 payments — averaging $21.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$158
  • Novo Nordisk$84
  • Pfizer$80
  • Sumitomo Pharma America, Inc.$52
  • Biohaven Pharmaceuticals, Inc.$49
  • Bayer$36
  • plus $260 from 13 others

What the payments were for

  • Food & beverage$719100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$719 in reported general payments places this provider in the 70th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$11,226
Medicare patients
79
Services billed
197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide11$13,804
JardianceEmpagliflozin13$13,404
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$8,034
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,348
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$1,582
Albuterol Sulfate HfaAlbuterol Sulfate53$1,254
Gabapentin57$987
Omeprazole44$750
Rosuvastatin Calcium54$720
Bupropion XlBupropion Hcl15$675
Duloxetine Hcl24$641
Metoprolol Succinate26$606
Levothyroxine Sodium42$566
Pantoprazole Sodium45$463
Atorvastatin Calcium52$441

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$84$13,80411 claims
Boehringer IngelheimJardiance$16$13,40413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Erie

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →